Physician profile
Angie Holifield
NPI 1366857443
$4,189.80
in general payments reported to CMS, 2019-2025
14 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $932 · 2022: $829 · 2023: $975 · 2024: $914 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,428.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,428.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,602.07 | 2021-2025 | Aveir, Gallant, Jot Dx |
| Boston Scientific Corporation | $468.31 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Varithena Administration Pack, General - Tachy |
| Medtronic, INC. | $446.44 | 2021-2024 | Cobalt Dr Mri Surescan, Selectsecure, Attain Command + Surevalve |
| Janssen Pharmaceuticals, INC | $198.56 | 2021-2022 | |
| Cvrx, INC. | $117.98 | 2023-2025 | Barostim Neo System |
| Pfizer INC. | $107.20 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $74.79 | 2021-2025 | |
| Atricure, INC. | $72.88 | 2024-2025 | Synergy Ablation System |
| Angiodynamics, INC. | $31.11 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $17.55 | 2021 | |
| Biosense Webster, INC. | $15.22 | 2024 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $14.18 | 2025 | Eliquis |
| Irhythm Technologies, INC. | $12.46 | 2021 | |
| Merck Sharp & Dohme LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Holifield listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.